MACM
NUVA

March Altus Capital Management’s NuVasive, Inc. NUVA Stock Holding History

March Altus Capital Management’s Portfolio NUVA Stock Details NUVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-163,675
Closed -$6.29M – 36
2014
Q1 		$6.29M Buy
+163,675
New +$6.01M 2.02% 25

Other funds holding NUVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

March Altus Capital Management's NUVA Position: Q2 2014 in Review

March Altus Capital Management sold out of NuVasive, Inc. (NUVA) in Q2 2014, closing a stake of 163,675 shares — an estimated $6.29M sold.

March Altus Capital Management first reported a position in NUVA in Q1 2014 and held it in 1 quarter. The position peaked at $6.29M in Q1 2014. 177 funds tracked by Wall St. Rank hold NUVA as of Q2 2014.

  • March Altus Capital Management reported no remaining NuVasive, Inc. position as of Q2 2014 after selling out during the quarter.
  • March Altus Capital Management sold 163,675 NuVasive, Inc. shares in Q2 2014, an estimated $6.29M.
  • March Altus Capital Management first reported a position in NuVasive, Inc. in Q1 2014 and held it in 1 quarter.
  • March Altus Capital Management's NuVasive, Inc. position peaked at $6.29M in Q1 2014.
  • 177 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q2 2014.

Based on March Altus Capital Management's 13F filing for Q2 2014, filed 14 Aug 2014.